Percutaneous Closure of Patent Ductus Arteriosus: A Multiinstitutional Registry Comparing Multiple Devices

被引:51
作者
Brunetti, Marissa A. [1 ,2 ]
Ringel, Richard [1 ]
Owada, Carl [3 ]
Coulson, John [1 ]
Jennings, Jacky M. [4 ,5 ]
Hoyer, Mark H. [6 ]
Everett, Allen D. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Dept Anesthesiol, Baltimore, MD 21287 USA
[3] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[4] Johns Hopkins Univ, Sch Med, Div Gen Pediat & Adolescent Med, Dept Pediat, Baltimore, MD 21287 USA
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[6] Indiana Univ, Sch Med, Dept Pediat, Bloomington, IN 47405 USA
关键词
congenital heart defects; heart catheterization; cardiovascular abnormalities; OCCLUSION; OCCLUDER; COILS;
D O I
10.1002/ccd.22538
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There are no guidelines and multiple devices available now for closure of PDA. Objective: We sought to determine which devices are used and their outcomes. Methods: Prospectively collected data on closure of PDA at 12 US catheterization labs was entered into the MAGIC data registry between November 2005 and September 2008. Results: PDA closure was accomplished in 357 of 359 attempted closures during the study period. Mean age, weight, and minimum ductal diameter were 4.3 +/- 6.8 years, 18.7 +/- 18.4 kg, and 2.1 +/- 1.4 mm, respectively. Devices used were Gianturco coils (161/359), Amplatzer Duct Occluder (ADO, 174/359), Flipper coils (18/359), and other devices (6/359). Gianturco coils had the least fluoroscopy and contrast exposure (8.7 +/- 7.5 min, P = 0.00001, 2.6 +/- 1.4 cm(3) kg(-1), P = 0.00001). Immediate angiographic success rates were 96.9% (156/161) for Gianturco coils, 89.7% (156/174) for the ADO, 100% (18/18) for Flipper coils, and 66.7% (4/6) for other devices. Major complication rates were 0.6% for Gianturco coils (1/161), 1.7% for ADO (3/174), and 83.3% for other devices (4/6). Minor complication rates by device were 1.9% for Gianturco coils (3/161), 2.3% for ADO (4/174), and 16.7% (1/6) for other devices. Conclusions: Gianturco coils, the ADO and Flipper coils were immediately successful with low complication profiles. The ADO and Gianturco coils were the predominate devices. The ADO was the device of choice for PDA > 3 mm with good success. In PDA < 3 mm, the Gianturco coil is as effective and safe as the ADO with less cost, less radiation, and less contrast exposure. (c) 2010 Wiley-Liss. Inc.
引用
收藏
页码:696 / 702
页数:7
相关论文
共 14 条
[1]  
Arora Ramesh, 2003, J Interv Cardiol, V16, P385, DOI 10.1046/j.1540-8183.2003.01005.x
[2]   The Amplatzer duct occluder: Experience in 209 patients [J].
Bilkis, AA ;
Alwi, M ;
Hasri, S ;
Haifa, AL ;
Geetha, K ;
Rehman, MA ;
Hasanah, I .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (01) :258-261
[3]   PERCUTANEOUS CLOSURE OF THE SMALL (LESS-THAN-2.5 MM) PATENT DUCTUS-ARTERIOSUS USING COIL EMBOLIZATION [J].
CAMBIER, PA ;
KIRBY, WC ;
WORTHAM, DC ;
MOORE, JW .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (08) :815-816
[4]   The influence of percutaneous closure of patent ductus arteriosus on left ventricular size and function - A prospective study using two- and three-dimensional echocardiography and measurements of serum natriuretic peptides [J].
Eerola, A ;
Jokinen, E ;
Boldt, T ;
Pihkala, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (05) :1060-1066
[5]   What is operative morbidity? Defining complications in a surgical registry database [J].
Jacobs, Jeffrey P. ;
Jacobs, Marshall L. ;
Mavroudis, Constantine ;
Maruszewski, Bohdan ;
Tchervenkov, Christo I. ;
Lacour-Gayet, Francois G. ;
Clarke, David R. ;
Yeh, Thomas, Jr. ;
Walters, Henry L., III ;
Kurosawa, Hiromi ;
Stellin, Giovanni ;
Ebels, Tjark ;
Elliott, Martin J. ;
Vener, David F. ;
Barach, Paul ;
Benavidez, Oscar J. ;
Bacha, Emile A. .
ANNALS OF THORACIC SURGERY, 2007, 84 (04) :1416-1421
[6]   ANGIOGRAPHIC CLASSIFICATION OF THE ISOLATED, PERSISTENTLY PATENT DUCTUS-ARTERIOSUS AND IMPLICATIONS FOR PERCUTANEOUS CATHETER OCCLUSION [J].
KRICHENKO, A ;
BENSON, LN ;
BURROWS, P ;
MOES, CAF ;
MCLAUGHLIN, P ;
FREEDOM, RM .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (12) :877-880
[7]   Interventional treatment of patent ductus arteriosus in 2004 [J].
Moore, JW ;
Levi, DS ;
Moore, SD ;
Schneider, DJ ;
Berdjis, F .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 64 (01) :91-101
[8]   Multicenter USA amplatzer patent ductus arteriosus occlusion device trial - Initial and one-year results [J].
Pass, RH ;
Hijazi, Z ;
Hsu, DT ;
Lewis, V ;
Hellenbrand, WE .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (03) :513-519
[9]   Percutaneous closure of patent ductus arteriosus: complementary use of detachable Cook patent ductus arteriosus coils and Amplatzer duct occluders [J].
Podnar, T ;
Gavora, P ;
Masura, J .
EUROPEAN JOURNAL OF PEDIATRICS, 2000, 159 (04) :293-296
[10]  
Porstmann W, 1967, Ger Med Mon, V12, P259